Arvind Utchanah
Director of Finance/CFO bij KNIGHT THERAPEUTICS INC.
Vermogen: 153 413 $ op 31-03-2024
Actieve functies van Arvind Utchanah
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KNIGHT THERAPEUTICS INC. | Director of Finance/CFO | 30-03-2020 | - |
| Public Communications Contact | - | - | |
| Corporate Officer/Principal | 20-06-2016 | 30-03-2020 |
Loopbaan van Arvind Utchanah
Eerdere bekende functies van Arvind Utchanah
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PALADIN LABS INC. | Comptroller/Controller/Auditor | 01-01-2012 | 01-06-2016 |
| Director of Finance/CFO | 01-01-2012 | 01-06-2016 |
Opleiding van Arvind Utchanah
| McGill University | Undergraduate Degree |
| Concordia University | Graduate Degree |
Statistieken
Internationaal
| Canada | 5 |
Operationeel
| Director of Finance/CFO | 2 |
| Public Communications Contact | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KNIGHT THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Paladin Labs Inc. operates as pharmaceutical company. It engages in developing, acquiring, in-licensing, marketing, and distributing innovative pharmaceutical products in Canada and internationally. The firm's products include Abstral, GlucaGen, Metadol, Plan B, Pennsaid, Seasonale, Testim, Twinject, Dexedrin, Tridural, and Trelstar. The company was founded by Jonathan Ross Goodman and Mark Beaudet on February 25, 1983 and is headquartered in Montreal, Canada. | Health Technology |
- Beurs
- Insiders
- Arvind Utchanah
- Ervaring
